The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations Source: ERJ Open Res, 5 (4) 00136-2019; 10.1183/23120541.00136-2019 Year: 2019
Can antibiotics prevent acute COPD exacerbation? A systematic review and meta-analysis Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013
A systematic review of the use of physiological tests assessing the acute response to treatment during exacerbations of COPD Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Systematic review of COPD re-exacerbation and exacerbation treatment failure definitions used in randomised controlled trials (RCTs) Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
The utility of tiotropium among patients with chronic obstructive pulmonary disease (COPD): An updated meta-analysis of randomized controlled trials Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regression Source: ERJ Open Res, 8 (1) 00261-2021; 10.1183/23120541.00261-2021 Year: 2022
²Hospital at home² versus inpatient care for patients with acute exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis Source: Eur Respir J 2003; 22: Suppl. 45, 445s Year: 2003
COPD treatment from pathophysiology to clinical trials Source: ERS Live 2007 Year: 2007
Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis Source: Eur Respir Rev, 29 (158) 200039; 10.1183/16000617.0039-2020 Year: 2020
How are recovery and recurrence of COPD exacerbations defined in observational studies? A systematic review Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
Omalizumab reduces asthma exacerbations and oral corticosteroid use in patients with severe allergic asthma: a systematic review of observational studies Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019
Late Breaking Abstract - First-time assessment of efficacy of candidate vaccine to prevent acute exacerbations of chronic obstructive pulmonary disease (AECOPD): multicentre, randomised, controlled, observer-blind phase 2b trial Source: Virtual Congress 2021 – ALERT: COPD Year: 2021
A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults Source: Eur Respir Rev, 28 (151) 180108; 10.1183/16000617.0108-2018 Year: 2019
Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019 Year: 2020
Procalcitonin-guided antibiotic therapy in acute exacerbations of COPD (AECOPD): a randomised trial - The ProCOLD Study Source: Eur Respir J 2005; 26: Suppl. 49, 464s Year: 2005
Placebo-controlled, double-blind trial of chronic, intermittent ‘pulse‘ therapy of moxifloxacin to prevent acute exacerbations in COPD patients with chronic bronchitis: baseline data Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
The clear evidence for pulmonary rehabilitation in chronic lung disease - a review of the most important randomised controlled trials Source: International Congress 2018 – PG14 The evolving world of pulmonary rehabilitation Year: 2018